RU2005121665A - Пребиотические композиции - Google Patents
Пребиотические композиции Download PDFInfo
- Publication number
- RU2005121665A RU2005121665A RU2005121665/13A RU2005121665A RU2005121665A RU 2005121665 A RU2005121665 A RU 2005121665A RU 2005121665/13 A RU2005121665/13 A RU 2005121665/13A RU 2005121665 A RU2005121665 A RU 2005121665A RU 2005121665 A RU2005121665 A RU 2005121665A
- Authority
- RU
- Russia
- Prior art keywords
- composition according
- composition
- medicament
- manufacture
- prevention
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 37
- 235000013406 prebiotics Nutrition 0.000 title 1
- 239000003814 drug Substances 0.000 claims 12
- 235000013305 food Nutrition 0.000 claims 11
- 238000004519 manufacturing process Methods 0.000 claims 10
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims 8
- 229940107187 fructooligosaccharide Drugs 0.000 claims 8
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims 8
- 150000003271 galactooligosaccharides Chemical class 0.000 claims 8
- 230000002265 prevention Effects 0.000 claims 8
- 241000894006 Bacteria Species 0.000 claims 6
- 230000000968 intestinal effect Effects 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 241000186000 Bifidobacterium Species 0.000 claims 2
- 241001112696 Clostridia Species 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 206010010774 Constipation Diseases 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 2
- 206010012735 Diarrhoea Diseases 0.000 claims 2
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 241000186660 Lactobacillus Species 0.000 claims 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 2
- 150000001720 carbohydrates Chemical class 0.000 claims 2
- 235000014633 carbohydrates Nutrition 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 230000001717 pathogenic effect Effects 0.000 claims 2
- 238000006116 polymerization reaction Methods 0.000 claims 2
- 230000004936 stimulating effect Effects 0.000 claims 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/203—Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Pediatric Medicine (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Claims (23)
1. Пищевая или фармацевтическая композиция, содержащая фруктоолигосахарид (ФОС) и галактоолигосахарид (ГОС).
2. Композиция по п.1, в которой ФОС содержит до 95 мас.% олигофруктозы, состоящей из цепочек со степенью полимеризации, варьирующей примерно от 2 до примерно 7, и ГОС содержит примерно до 95 мас.% олигогалактозы, состоящей из цепочек со степенью полимеризации, варьирующей примерно от 2 до примерно 7.
3. Композиция по п.1, в которой соотношение масс ФОС:ГОС составляет примерно от 0,01 до примерно 50.
4. Композиция по п.1, в которой соотношение масс ФОС:ГОС составляет примерно от 0,5 до примерно 2.
5. Композиция по п.1, в которой количество смеси ФОС и ГОС составляет примерно от 0,05 до примерно 40 мас.% от общей массы композиции.
6. Композиция по одному из пп.1-5, которая является высококалорийной композицией.
7. Композиция по одному из пп.1-5, которая включает примерно более 1 эн.% белка от общего содержания калорий в композиции.
8. Композиция по одному из пп.1-5, которая является законченной формулой питания.
9. Композиция по одному из пп.1-5, которая содержит в 100 мл примерно от 1 до примерно 3 г ФОС, примерно от 1 до примерно 3 г ГОС, примерно от 2 до примерно 20 г белков, примерно от 1 до примерно 30 г углеводов, примерно от 0,5 до примерно 20 г жиров, а также минералы и витамины.
10. Композиция по п.9, которая содержит в 100 мл примерно 1,25 г ФОС, примерно 1,25 г ГОС, примерно 9 г белков, примерно 22 г углеводов и примерно 9 г жиров.
11. Композиция по п.9, готовая к употреблению.
12. Композиция по одному из пп.1-5 для применения в качестве лекарственного средства.
13. Применение композиции по одному из пп.1-5 для получения лекарственного средства или пищевой композиции для лечения или предупреждения желудочно-кишечных расстройств, например диареи и запора.
14. Применение композиции по одному из пп.1-5 для получения лекарственного средства или пищевой композиции для поддержания и/или восстановления кишечной флоры.
15. Применение композиции по одному из пп.1-5 для получения лекарственного средства или пищевой композиции для предупреждения или лечения воспаления кишечника, например язвенного колита, болезни Крона и/или предупреждения рака толстой кишки.
16. Применение композиции по одному из пп.1-5 для получения лекарственного средства или пищевой композиции для стимуляции роста бифидобактерий и/или лактобацилл и/или ингибирования роста, по меньшей мере, одной группы бактерий из числа бактероидов, клостридий, колиформ, сульфатредуцирующих бактерий.
17. Применение композиции по одному из пп.1-5 для получения лекарственного средства или пищевой композиции для предупреждения или лечения инфекции, вызываемой патогенными кишечными бактериями.
18. Композиция по п.11 для применения в качестве лекарственного средства.
19. Применение композиции по п.11 для получения лекарственного средства или пищевой композиции для лечения или предупреждения желудочно-кишечных расстройств, например диареи и запора.
20. Применение композиции по п.11 для получения лекарственного средства или пищевой композиции для поддержания и/или восстановления кишечной флоры.
21. Применение композиции по п.11 для получения лекарственного средства или пищевой композиции для предупреждения или лечения воспаления кишечника, например язвенного колита, болезни Крона и/или предупреждения рака толстой кишки.
22. Применение композиции по п.11 для получения лекарственного средства или пищевой композиции для стимуляции роста бифидобактерий и/или лактобацилл и/или ингибирования роста, по меньшей мере, одной группы бактерий из числа бактероидов, клостридий, колиформ, сульфатредуцирующих бактерий.
23. Применение композиции по п.11 для получения лекарственного средства или пищевой композиции для предупреждения или лечения инфекции, вызываемой патогенными кишечными бактериями.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0229015.3 | 2002-12-12 | ||
GBGB0229015.3A GB0229015D0 (en) | 2002-12-12 | 2002-12-12 | New Compound |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2005121665A true RU2005121665A (ru) | 2006-04-27 |
RU2358474C2 RU2358474C2 (ru) | 2009-06-20 |
Family
ID=9949583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2005121665/13A RU2358474C2 (ru) | 2002-12-12 | 2003-12-11 | Пребиотические композиции |
Country Status (19)
Country | Link |
---|---|
US (2) | US7794746B2 (ru) |
EP (1) | EP1571923B1 (ru) |
JP (1) | JP4491348B2 (ru) |
CN (1) | CN1731938B (ru) |
AU (1) | AU2003294835B2 (ru) |
BR (1) | BRPI0317272B1 (ru) |
CA (1) | CA2508693C (ru) |
DK (1) | DK1571923T3 (ru) |
ES (1) | ES2449016T3 (ru) |
GB (1) | GB0229015D0 (ru) |
HK (1) | HK1083054A1 (ru) |
MX (1) | MXPA05006266A (ru) |
NZ (1) | NZ540576A (ru) |
PL (1) | PL213665B1 (ru) |
PT (1) | PT1571923E (ru) |
RU (1) | RU2358474C2 (ru) |
TW (1) | TWI337080B (ru) |
WO (1) | WO2004052121A1 (ru) |
ZA (1) | ZA200504385B (ru) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2478309C2 (ru) * | 2007-12-21 | 2013-04-10 | Н.В. Нютрисиа | Применение сфингомиелина и неперевариваемых углеводов для нормализации микробиоты кишечника |
RU2529160C2 (ru) * | 2009-06-12 | 2014-09-27 | Н.В. Нютрисиа | Синергетическая смесь бета-галактоолигосахаридов с бета-1,3 и бета-1,4/1,6 связями |
Families Citing this family (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
US7608291B2 (en) * | 2000-03-10 | 2009-10-27 | Mars, Inc. | Treatment of infection in animals |
GB0229015D0 (en) | 2002-12-12 | 2003-01-15 | Novartis Nutrition Ag | New Compound |
DE10328180A1 (de) * | 2003-06-16 | 2005-01-13 | Südzucker AG Mannheim/Ochsenfurt | Verwendung von Isomalt als Präbiotikum |
ATE360682T1 (de) * | 2003-06-30 | 2007-05-15 | Clasado Inc | Neue galactooligosaccharidzusammensetzung und herstellung davon |
EP1597978A1 (en) * | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
US8252769B2 (en) | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
US20080126195A1 (en) | 2004-07-22 | 2008-05-29 | Ritter Andrew J | Methods and Compositions for Treating Lactose Intolerance |
EP1629727A1 (en) | 2004-08-24 | 2006-03-01 | N.V. Nutricia | Composition containing fermentable polysaccharides |
PT1629850E (pt) * | 2004-08-24 | 2007-08-14 | Nutricia Nv | Composição nutricional que compreende a administração de oligossacarídeos indigeríveis |
WO2006035979A1 (ja) * | 2004-09-29 | 2006-04-06 | Asama Chemical Co., Ltd. | 乳清タンパク、乳由来の抗体または抗体を含む機能性組成物または食品 |
RU2442438C2 (ru) * | 2005-02-21 | 2012-02-20 | Нестек С.А. | Смесь олигосахаридов |
US7572474B2 (en) * | 2005-06-01 | 2009-08-11 | Mead Johnson Nutrition Company | Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants |
DE602006008985D1 (de) * | 2005-12-16 | 2009-10-15 | Nutricia Nv | Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund |
GB0525857D0 (en) * | 2005-12-20 | 2006-02-01 | Product and process | |
GB0601901D0 (en) * | 2006-01-31 | 2006-03-08 | Product and Process | |
GB0606112D0 (en) | 2006-03-28 | 2006-05-03 | Product and process | |
US8729051B2 (en) | 2006-05-30 | 2014-05-20 | Nutrition Sciences N.V./S.A. | Tri- and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens |
SI2076271T1 (sl) * | 2006-10-02 | 2011-12-30 | Friesland Brands Bv | Inhibicija toksinov kolere z galatooligosaharidi (GOS) |
JP5627184B2 (ja) * | 2007-01-26 | 2014-11-19 | 天野エンザイム株式会社 | 酵素組成物及びその用途 |
IL181431A0 (en) * | 2007-02-19 | 2007-07-04 | Micha Shemer | Fruit juice and puree with a lowered amount of available sugars |
RU2500612C2 (ru) | 2007-09-06 | 2013-12-10 | Дзе Кока-Кола Компани | Система и способ контроля и регулирования розлива ингредиентов для приготовления продукта |
CN102123938A (zh) | 2007-09-06 | 2011-07-13 | 可口可乐公司 | 用于提供混合饮料分配器中的份量控制编程的系统和方法 |
US20110223248A1 (en) * | 2007-12-12 | 2011-09-15 | Ritter Pharmaceuticals, Inc. | Methods and compositions for treating lactose intolerance |
KR101419194B1 (ko) * | 2008-01-10 | 2014-07-14 | 뉴트리 가부시키가이샤 | 고령자의 영양 상태 개선, 발열 횟수의 저하 및/또는 면역능 향상을 위한 조성물 |
GB0809921D0 (en) * | 2008-05-30 | 2008-07-09 | Clasado Inc | Product and process therefor |
CN102123715B (zh) | 2008-06-13 | 2014-12-17 | N.V.努特里奇亚 | 刺激免疫系统的营养物 |
EP2400839B1 (en) | 2009-02-24 | 2016-09-07 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
CN101503720B (zh) * | 2009-02-24 | 2011-08-24 | 中国海洋大学 | 一种具有益生元作用的微生物寡糖的制备方法 |
US8785160B2 (en) * | 2009-02-24 | 2014-07-22 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
US8425930B2 (en) * | 2009-03-13 | 2013-04-23 | The Regents Of The University Of California | Prebiotic oligosaccharides |
WO2010106384A1 (fr) * | 2009-03-16 | 2010-09-23 | Societe La Biochimie Appliquee (Solabia) | Compositions nutraceutiques, pharmaceutiques ou alimentaires a base de gluco-oligosaccharides |
WO2010117274A1 (en) * | 2009-04-08 | 2010-10-14 | Stichting Top Institute Food And Nutrition | Carbohydrates enhancing the production of a c5 and/or a c6 scfa |
GB0906983D0 (en) * | 2009-04-23 | 2009-06-03 | Clasado Inc | Novel use |
US11065268B2 (en) | 2009-05-27 | 2021-07-20 | Clasado Research Services Limited | Method of preventing diarrhoea |
EP3248605A1 (en) | 2009-07-06 | 2017-11-29 | Children's Hospital Medical Center | Inhibiting inflammation with milk oligosaccharides |
WO2011020853A1 (en) * | 2009-08-18 | 2011-02-24 | Cosucra-Groupe Warcoing Sa | Compositions containing mixtures of fermentable fibers |
GB0915315D0 (en) | 2009-09-03 | 2009-10-07 | Univ Manchester | Use of non-digestible oligosaccharides |
US20110189342A1 (en) * | 2010-02-01 | 2011-08-04 | Jeong Hea-Seok | High-purity galactooligosaccharides and uses thereof |
KR20130102541A (ko) | 2010-08-25 | 2013-09-17 | 테이트 앤드 라일 인그리디언츠 어메리카즈 엘엘씨 | 신바이오틱 제품 |
EP2658549B1 (en) | 2010-12-31 | 2020-06-03 | Abbott Laboratories | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
EP2658547A1 (en) | 2010-12-31 | 2013-11-06 | Abbott Laboratories | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
EP2478779A1 (en) | 2011-01-24 | 2012-07-25 | Biotechnobel | Composition for providing beneficial health effects |
CN102613294A (zh) * | 2011-01-31 | 2012-08-01 | 内蒙古蒙牛乳业(集团)股份有限公司 | 一种低聚糖牛乳 |
JP5837315B2 (ja) * | 2011-03-25 | 2015-12-24 | イーエヌ大塚製薬株式会社 | 炎症性疾患用栄養組成物 |
EP2517699A1 (en) | 2011-04-29 | 2012-10-31 | Biotechnobel SA | Composition for prevention and treatment of arthritis |
CA2842672A1 (en) | 2011-07-22 | 2013-01-31 | Abbott Laboratories | Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
US9997006B2 (en) | 2011-08-26 | 2018-06-12 | Elwha Llc | Treatment system and method for ingestible product dispensing system and method |
US9947167B2 (en) | 2011-08-26 | 2018-04-17 | Elwha Llc | Treatment system and method for ingestible product dispensing system and method |
US20130054255A1 (en) * | 2011-08-26 | 2013-02-28 | Elwha LLC, a limited liability company of the State of Delaware | Controlled substance authorization and method for ingestible product preparation system and method |
US8892249B2 (en) | 2011-08-26 | 2014-11-18 | Elwha Llc | Substance control system and method for dispensing systems |
US10192037B2 (en) | 2011-08-26 | 2019-01-29 | Elwah LLC | Reporting system and method for ingestible product preparation system and method |
US8989895B2 (en) | 2011-08-26 | 2015-03-24 | Elwha, Llc | Substance control system and method for dispensing systems |
US9111256B2 (en) | 2011-08-26 | 2015-08-18 | Elwha Llc | Selection information system and method for ingestible product preparation system and method |
US20130330447A1 (en) | 2012-06-12 | 2013-12-12 | Elwha LLC, a limited liability company of the State of Delaware | Substrate Structure Deposition Treatment System And Method For Ingestible Product System and Method |
US10121218B2 (en) | 2012-06-12 | 2018-11-06 | Elwha Llc | Substrate structure injection treatment system and method for ingestible product system and method |
US9785985B2 (en) | 2011-08-26 | 2017-10-10 | Elwha Llc | Selection information system and method for ingestible product preparation system and method |
US10026336B2 (en) | 2011-08-26 | 2018-07-17 | Elwha Llc | Refuse intelligence acquisition system and method for ingestible product preparation system and method |
US9619958B2 (en) | 2012-06-12 | 2017-04-11 | Elwha Llc | Substrate structure duct treatment system and method for ingestible product system and method |
US9037478B2 (en) | 2011-08-26 | 2015-05-19 | Elwha Llc | Substance allocation system and method for ingestible product preparation system and method |
US9922576B2 (en) | 2011-08-26 | 2018-03-20 | Elwha Llc | Ingestion intelligence acquisition system and method for ingestible material preparation system and method |
US9240028B2 (en) | 2011-08-26 | 2016-01-19 | Elwha Llc | Reporting system and method for ingestible product preparation system and method |
BR112014004772A2 (pt) | 2011-08-29 | 2017-03-21 | Abbott Lab | oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal |
RU2473347C1 (ru) * | 2011-11-09 | 2013-01-27 | Сергей Константинович Панюшин | Композиция пребиотиков для нормализации микрофлоры организма |
RU2484828C1 (ru) * | 2012-04-11 | 2013-06-20 | Анна Викторовна Филимонова | Витаминно-минеральное средство: порошок для приготовления раствора для внутреннего применения |
WO2013172714A1 (en) * | 2012-05-18 | 2013-11-21 | N.V. Nutricia | Treatment of conditions associated with mycotoxin exposure |
WO2013187755A1 (en) | 2012-06-14 | 2013-12-19 | N.V. Nutricia | Fermented infant formula with non digestible oligosaccharides |
CN102861108B (zh) * | 2012-09-07 | 2013-12-25 | 李宁 | 一种用于治疗便秘的药物组合物及其应用 |
US20140122120A1 (en) * | 2012-10-30 | 2014-05-01 | Pacesetter, Inc. | Systems and methods for providing photo-based patient verification for use with implantable medical device programmers |
US10626460B2 (en) | 2013-02-21 | 2020-04-21 | Children's Hospital Medical Center | Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease |
GB201312713D0 (en) * | 2013-03-22 | 2013-08-28 | Weaver Connie M | Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption |
GB201305708D0 (en) * | 2013-03-28 | 2013-05-15 | Clasado Inc | Novel use |
CA2966074A1 (en) * | 2013-11-05 | 2016-05-12 | Optibiotix Limited | Prebiotic composition and its method of production |
AU2015287703A1 (en) | 2014-07-09 | 2017-02-16 | Cadena Bio, Inc. | Oligosaccharide compositions and methods for producing thereof |
ES2755042T3 (es) | 2015-01-26 | 2020-04-21 | Cadena Bio Inc | Composiciones de oligosacáridos para el uso como alimento para animales y sus métodos para producirlas |
AU2016212030B2 (en) | 2015-01-26 | 2021-06-17 | Kaleido Biosciences, Inc. | Glycan therapeutics and related methods thereof |
RU2017134547A (ru) * | 2015-04-23 | 2019-04-09 | Калейдо Байосайенсиз, Инк. | Регуляторы микробиома и соответствующие варианты их применения |
AU2016253010B2 (en) | 2015-04-23 | 2021-06-10 | Kaleido Biosciences, Inc. | Glycan therapeutics and methods of treatment |
EP3288389A4 (en) | 2015-04-28 | 2018-10-10 | Children's Hospital Medical Center | Use of oligosaccharide compositions to enhance weight gain |
GB201509023D0 (en) * | 2015-05-27 | 2015-07-08 | Optibiotix Ltd | Compositions and methods of production thereof |
RU2721257C2 (ru) * | 2015-06-23 | 2020-05-18 | Сосьете Де Продюи Нестле С.А. | Питательные композиции и детские смеси, содержащие олигофруктозу, для снижения нагрузки патогенных бактерий в кишечнике младенцев и детей младшего возраста |
EP3334437A1 (en) * | 2015-08-25 | 2018-06-20 | Kaleido Biosciences, Inc. | Glycan compositions and uses thereof |
WO2017058175A1 (en) | 2015-09-29 | 2017-04-06 | Kimberly-Clark Worldwide, Inc. | Synergistic composition for maintenance of healthy balance of microflora |
CN105287561A (zh) * | 2015-11-25 | 2016-02-03 | 上海交通大学医学院附属瑞金医院 | 一种治疗溃疡性结肠炎的药物组合物 |
WO2017212064A1 (en) * | 2016-06-10 | 2017-12-14 | N.V. Nutricia | Risk of allergy and nutrition to reduce that risk |
CN109689067A (zh) * | 2016-07-13 | 2019-04-26 | 卡莱多生物科技有限公司 | 聚糖组合物和使用方法 |
CN107927775A (zh) * | 2017-10-31 | 2018-04-20 | 天津市益倍建生物技术有限公司 | 一种含白藜芦醇的治疗溃疡性结肠炎的组合物 |
CN107981359A (zh) * | 2017-12-12 | 2018-05-04 | 河北三元食品有限公司 | 益生元组合物及其应用 |
CN107912589A (zh) * | 2017-12-21 | 2018-04-17 | 广州莱可福生物科技有限公司 | 含益生菌且可改善肠道和免疫力的压片糖果及其制备方法 |
CN108338984A (zh) * | 2018-02-26 | 2018-07-31 | 量子高科(中国)生物股份有限公司 | 具有清肠作用的组合物及其制备方法和在碳水化合物组件特医配方食品中的应用 |
EP3542641B1 (de) | 2018-03-20 | 2023-07-12 | Universität Hohenheim | Lactulosehaltiges produkt sowie verfahren zur herstellung eines lactulosehaltigen produkts |
EP3877424A2 (en) | 2018-11-08 | 2021-09-15 | Kaleido Biosciences, Inc. | Oligosaccharide compositions and methods of use thereof |
US20220047659A1 (en) * | 2018-12-18 | 2022-02-17 | Centro De Retina Medica Y Quirurgica, S.C. | Symbiotic supplement formulation for improving intestinal microbiota |
CN110237092A (zh) * | 2019-06-11 | 2019-09-17 | 厦门蓝特生物科技有限公司 | 一种治疗便秘的组合物 |
CN112806577B (zh) * | 2019-11-15 | 2021-11-26 | 内蒙古伊利实业集团股份有限公司 | 产丁酸的益生元益生菌增效组合 |
JP7010509B2 (ja) * | 2020-01-15 | 2022-01-26 | 一般社団法人 Unical | 新規配合スポーツ飲料およびその調製のための顆粒剤 |
CN112641098A (zh) * | 2020-12-15 | 2021-04-13 | 山东欣瑞文生物科技有限公司 | 一种具有调理肠胃腹泻功能的阿拉伯胶组合物 |
KR102453998B1 (ko) * | 2022-01-07 | 2022-10-14 | (주)네오크레마 | 갈락토올리고당을 포함하는 염증성 장질환의 예방, 개선 또는 치료용 조성물 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04311384A (ja) | 1991-04-11 | 1992-11-04 | Calpis Food Ind Co Ltd:The | 植物組織培養方法及び植物組織培養用生長促進剤 |
US5780451A (en) | 1994-04-01 | 1998-07-14 | Abbott Laboratories | Nutritional product for a person having ulcerative colitis |
US5444054A (en) | 1994-04-01 | 1995-08-22 | Abbott Labatories | Method of treating ulcerative colitis |
US5952314A (en) | 1994-04-01 | 1999-09-14 | Demichele; Stephen Joseph | Nutritional product for a person having ulcerative colitis |
US5531989A (en) | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Immunoglobulin and fiber-containing composition for human gastrointestinal health |
US5972905A (en) | 1995-06-14 | 1999-10-26 | Institute Of Immunology Co., Ltd. | Use of oligosaccharides for the treatment of pruritus cutaneus associated with renal failure |
EP1254664A3 (en) | 1995-07-10 | 2004-01-02 | Abbott Laboratories | Enteral products containing indigestible oligosaccharides for treating and preventing otitis media in humans |
US5827526A (en) | 1995-07-11 | 1998-10-27 | Abbott Laboratories | Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans |
DE69506095T2 (de) | 1995-08-04 | 1999-06-24 | Nutricia Nv | Diätfasern enthaltende Nahrungszusammensetzung |
MY115050A (en) | 1995-10-16 | 2003-03-31 | Mead Johnson Nutrition Co | Diabetic nutritional product having controlled absorption of carbohydrate |
WO1997029763A1 (en) | 1996-02-14 | 1997-08-21 | The Procter & Gamble Company | Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor |
JP4008974B2 (ja) | 1996-12-12 | 2007-11-14 | 森永乳業株式会社 | ビフィズス菌増殖促進組成物及びその用途 |
TR199901365T2 (xx) | 1996-12-20 | 1999-12-21 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Aces�lfam-K/aspartam kar���m�n�n tatl�l�k derecesini artt�rmak i�in oligosakarid kullan�m� |
WO1999002042A2 (fr) * | 1997-07-05 | 1999-01-21 | Societe Des Produits Nestle S.A. | Dessert congele contenant des bacteries lactiques et des fibres fermentescibles |
JPH11302182A (ja) | 1998-04-16 | 1999-11-02 | Otsuka Pharmaceut Co Ltd | 抗水虫組成物 |
DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
IT1304170B1 (it) | 1998-12-15 | 2001-03-08 | Novartis Nutrition Ag | Composti organici |
NL1014380C2 (nl) * | 2000-02-14 | 2001-08-15 | Friesland Brands Bv | Darmwandversterkend voedingsmiddel. |
ATE283697T1 (de) | 2000-03-01 | 2004-12-15 | Nestle Sa | Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort |
EP1175905A1 (en) | 2000-07-24 | 2002-01-30 | Societe Des Produits Nestle S.A. | Nutritional Composition |
JP2002051731A (ja) | 2000-08-11 | 2002-02-19 | Toyo Shinyaku:Kk | 麦若葉由来の素材を含む便秘改善食品 |
GB0028238D0 (en) | 2000-11-20 | 2001-01-03 | Cerestar Holding Bv | Indigestible oligosaccharides and magnesium absorption in humans |
PL204217B1 (pl) | 2000-12-27 | 2009-12-31 | Nutricia Nv | Kompozycja odżywcza, dodatek odżywczy oraz zastosowanie oligosacharydów |
GB0229015D0 (en) | 2002-12-12 | 2003-01-15 | Novartis Nutrition Ag | New Compound |
JP4311384B2 (ja) | 2005-08-09 | 2009-08-12 | 日産自動車株式会社 | ハイブリット車両の発電制御方法 |
-
2002
- 2002-12-12 GB GBGB0229015.3A patent/GB0229015D0/en not_active Ceased
-
2003
- 2003-11-25 US US10/721,652 patent/US7794746B2/en active Active
- 2003-12-10 TW TW092134808A patent/TWI337080B/zh not_active IP Right Cessation
- 2003-12-11 RU RU2005121665/13A patent/RU2358474C2/ru not_active IP Right Cessation
- 2003-12-11 DK DK03785796.8T patent/DK1571923T3/en active
- 2003-12-11 PT PT37857968T patent/PT1571923E/pt unknown
- 2003-12-11 BR BRPI0317272A patent/BRPI0317272B1/pt active IP Right Grant
- 2003-12-11 EP EP03785796.8A patent/EP1571923B1/en not_active Revoked
- 2003-12-11 CN CN2003801055586A patent/CN1731938B/zh not_active Expired - Lifetime
- 2003-12-11 WO PCT/EP2003/014087 patent/WO2004052121A1/en active IP Right Grant
- 2003-12-11 CA CA2508693A patent/CA2508693C/en not_active Expired - Lifetime
- 2003-12-11 MX MXPA05006266A patent/MXPA05006266A/es active IP Right Grant
- 2003-12-11 AU AU2003294835A patent/AU2003294835B2/en not_active Expired
- 2003-12-11 PL PL377411A patent/PL213665B1/pl unknown
- 2003-12-11 JP JP2004558076A patent/JP4491348B2/ja not_active Expired - Lifetime
- 2003-12-11 ES ES03785796.8T patent/ES2449016T3/es not_active Expired - Lifetime
- 2003-12-11 NZ NZ540576A patent/NZ540576A/en unknown
-
2005
- 2005-05-30 ZA ZA200504385A patent/ZA200504385B/en unknown
-
2006
- 2006-03-09 HK HK06103077.4A patent/HK1083054A1/xx not_active IP Right Cessation
-
2010
- 2010-07-19 US US12/838,741 patent/US8241658B2/en not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2478309C2 (ru) * | 2007-12-21 | 2013-04-10 | Н.В. Нютрисиа | Применение сфингомиелина и неперевариваемых углеводов для нормализации микробиоты кишечника |
RU2608215C2 (ru) * | 2007-12-21 | 2017-01-17 | Н.В. Нютрисиа | Применение сфингомиелина и неперевариваемых углеводов для нормализации микробиоты кишечника |
RU2529160C2 (ru) * | 2009-06-12 | 2014-09-27 | Н.В. Нютрисиа | Синергетическая смесь бета-галактоолигосахаридов с бета-1,3 и бета-1,4/1,6 связями |
Also Published As
Publication number | Publication date |
---|---|
EP1571923B1 (en) | 2014-01-22 |
EP1571923A1 (en) | 2005-09-14 |
US8241658B2 (en) | 2012-08-14 |
PT1571923E (pt) | 2014-03-28 |
AU2003294835B2 (en) | 2007-05-03 |
CN1731938A (zh) | 2006-02-08 |
TWI337080B (en) | 2011-02-11 |
PL377411A1 (pl) | 2006-02-06 |
US20040131659A1 (en) | 2004-07-08 |
ZA200504385B (en) | 2006-07-26 |
BR0317272A (pt) | 2005-11-08 |
WO2004052121A1 (en) | 2004-06-24 |
MXPA05006266A (es) | 2005-08-19 |
CA2508693A1 (en) | 2004-06-24 |
PL213665B1 (pl) | 2013-04-30 |
AU2003294835A1 (en) | 2004-06-30 |
US20110003768A1 (en) | 2011-01-06 |
BRPI0317272B1 (pt) | 2016-03-22 |
NZ540576A (en) | 2007-03-30 |
TW200505462A (en) | 2005-02-16 |
CN1731938B (zh) | 2011-12-28 |
ES2449016T3 (es) | 2014-03-17 |
GB0229015D0 (en) | 2003-01-15 |
US7794746B2 (en) | 2010-09-14 |
CA2508693C (en) | 2013-08-13 |
HK1083054A1 (en) | 2006-06-23 |
DK1571923T3 (en) | 2014-02-17 |
JP4491348B2 (ja) | 2010-06-30 |
RU2358474C2 (ru) | 2009-06-20 |
JP2006509797A (ja) | 2006-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2005121665A (ru) | Пребиотические композиции | |
AU759388B2 (en) | Pharmaceutical compositions containing lipase inhibitors and chitosan | |
ES2355754T3 (es) | Composición nutricional. | |
ES2781848T3 (es) | Oligosacáridos inmunomoduladores | |
ES2641364T3 (es) | Probióticos, IgA secretor e inflamación | |
ES2622091T5 (es) | Composiciones que contienen mezclas de fibras fermentables | |
AU2004317895B2 (en) | Dietary supplement and method for treating digestive system-related disorders | |
AU2004228936A1 (en) | Synbiotic combination | |
CN107495383A (zh) | 一种润肠通便复合益生元及其制备方法与应用 | |
EP2014181A2 (en) | Compositions based on prebiotic and immunogenic ingredients for the prevention and treatment of gastroenteric disorders caused by dysbiosis and/or alterations of the normal intestinal flora | |
CN1708234A (zh) | 抗氧化组合物 | |
KR20050057419A (ko) | 탄수화물 및 탄수화물 조성물의 신규한 용도 | |
WO2013132668A1 (ja) | イミダゾールペプチドとケルセチン配糖体を含有する組成物 | |
CN113355255A (zh) | 罗伊氏乳杆菌lm1071菌株及包含其培养物的组合物 | |
ES2398227T3 (es) | Prebióticos de glucooligosacáridos para la prevención de la diabetes de tipo II | |
EP2234612B1 (en) | Composition for stimulating natural killer cell activity | |
CN114258961A (zh) | 乳双歧杆菌与母乳低聚糖组合物在婴幼儿配方食品中的应用 | |
TW201100084A (en) | Compositions comprising oligosaccharides | |
Sharma et al. | Prebiotics: A review of therapeutic potential | |
RU2737891C2 (ru) | Применение антибиотиков со специфичными терапевтическими активностями в комбинации с одновременным применением лактобацилл и/или бифидобактерий с непередающейся устойчивостью к антибиотикам, имеющих такое же терапевтическое показание | |
CN101049312B (zh) | 一种药物组合物、其制备方法及其用途 | |
JP2021504421A5 (ru) | ||
BR112020006693A2 (pt) | uma composição farmacêutica que compreende uma combinação de probiótico e prebiótico para tratar retardo de crescimento | |
JP6848962B2 (ja) | 行動体力向上剤 | |
CA2434573A1 (en) | Agent for protection against microorganism infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC4A | Invention patent assignment |
Effective date: 20100210 |
|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20141212 |